RNU6-1137P

Across TCGA pan-cancer cohorts, RNU6-1137P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1137P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1137P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1137P expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

KIRC, THCA, and STAD are the cancer types where RNU6-1137P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.548	0.804	<.001	144	view →
THCA	DFS	Tertile	All	0.777	0.905	.004	39	view →
STAD	DFS	Tertile	All	0.107	0.499	.017	36	view →
READ	DFS	Tertile	III,IV	0.182	0.745	.007	36	view →
OV	OS	Tertile	IV	0.022	0.760	<.001	36	view →
LUAD	OS	Tertile	IV	0.114	0.560	.038	18	view →
PRAD	OS	Tertile	All	0.781	0.990	<.001	18	view →
HNSC	OS	Tertile	All	0.910	0.743	.028	18	view →
LGG	OS	Tertile	All	0.836	0.915	.002	9	view →
SKCM	DFS	Tertile	IV	1.000	0.124	.046	3	view →
BLCA	DFS	Tertile	IV	0.761	0.194	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1137P–KIRC (OS)

Open the KIRC breakdown →